ArticleCommunications chemistry2026
Multicomponent Betti reaction affords covalent organic framework nanoreactor for palladium-catalyzed nitroarene reduction.
Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multicomponent reactions (MCRs) offer a sustainable and efficient pathway to complex molecular architectures. Here, we show the design and synthesis of a α-amino(2-hydroxybenzyl)-linked covalent organic framework (Betti-COF) via a one-pot, three-component solvothermal Betti reaction. This approach expands the scope of the MCR-based COF synthesis strategies by introducing a multicomponent pathway to highly ordered crystalline frameworks without the need for step-by-step linkage construction. The resulting s-Betti-COF exhibits a distinct hollow spherical morphology, high thermal stability, and robust porosity. This framework provides ideal support for the immobilization of small palladium nanoparticles (1-2 nm) within its pores to form the s-Betti-COF nanocomposite. The prepared samples were characterized by FT-IR, DNP-enhanced
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.